nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—UGT1A1—Naltrexone—alcohol dependence	0.271	0.558	CbGbCtD
Pazopanib—ABCB1—Naltrexone—alcohol dependence	0.0538	0.111	CbGbCtD
Pazopanib—CYP1A2—Citalopram—alcohol dependence	0.0408	0.0838	CbGbCtD
Pazopanib—ABCB1—Citalopram—alcohol dependence	0.0356	0.0733	CbGbCtD
Pazopanib—CYP2D6—Citalopram—alcohol dependence	0.0336	0.069	CbGbCtD
Pazopanib—CYP3A4—Disulfiram—alcohol dependence	0.03	0.0616	CbGbCtD
Pazopanib—CYP3A4—Citalopram—alcohol dependence	0.0214	0.0439	CbGbCtD
Pazopanib—Rhinorrhoea—Citalopram—alcohol dependence	0.000917	0.00404	CcSEcCtD
Pazopanib—Ageusia—Citalopram—alcohol dependence	0.000917	0.00404	CcSEcCtD
Pazopanib—Hot flush—Naltrexone—alcohol dependence	0.00091	0.00401	CcSEcCtD
Pazopanib—Hyponatraemia—Acamprosate—alcohol dependence	0.000903	0.00398	CcSEcCtD
Pazopanib—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.000903	0.00398	CcSEcCtD
Pazopanib—Dysphonia—Citalopram—alcohol dependence	0.000903	0.00398	CcSEcCtD
Pazopanib—Menopausal symptoms—Naltrexone—alcohol dependence	0.000902	0.00398	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.0009	0.00397	CcSEcCtD
Pazopanib—Endocrine disorder—Citalopram—alcohol dependence	0.000896	0.00395	CcSEcCtD
Pazopanib—Lethargy—Naltrexone—alcohol dependence	0.000869	0.00383	CcSEcCtD
Pazopanib—Face oedema—Acamprosate—alcohol dependence	0.000868	0.00383	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.000851	0.00375	CcSEcCtD
Pazopanib—Blood creatinine increased—Acamprosate—alcohol dependence	0.000843	0.00371	CcSEcCtD
Pazopanib—Liver function test abnormal—Acamprosate—alcohol dependence	0.000831	0.00366	CcSEcCtD
Pazopanib—Dry skin—Acamprosate—alcohol dependence	0.000825	0.00363	CcSEcCtD
Pazopanib—Skin discolouration—Citalopram—alcohol dependence	0.000823	0.00363	CcSEcCtD
Pazopanib—Rectal haemorrhage—Citalopram—alcohol dependence	0.000823	0.00363	CcSEcCtD
Pazopanib—Face oedema—Naltrexone—alcohol dependence	0.000822	0.00362	CcSEcCtD
Pazopanib—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.000817	0.0036	CcSEcCtD
Pazopanib—Breast disorder—Acamprosate—alcohol dependence	0.000813	0.00358	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00081	0.00357	CcSEcCtD
Pazopanib—Paraesthesia—Disulfiram—alcohol dependence	0.000806	0.00355	CcSEcCtD
Pazopanib—Somnolence—Disulfiram—alcohol dependence	0.000798	0.00352	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.000793	0.0035	CcSEcCtD
Pazopanib—Dehydration—Naltrexone—alcohol dependence	0.000792	0.00349	CcSEcCtD
Pazopanib—Blood bilirubin increased—Citalopram—alcohol dependence	0.000785	0.00346	CcSEcCtD
Pazopanib—Hepatic enzyme increased—Citalopram—alcohol dependence	0.000785	0.00346	CcSEcCtD
Pazopanib—Abdominal distension—Acamprosate—alcohol dependence	0.000783	0.00345	CcSEcCtD
Pazopanib—Abdominal pain upper—Naltrexone—alcohol dependence	0.000777	0.00343	CcSEcCtD
Pazopanib—Fatigue—Disulfiram—alcohol dependence	0.000774	0.00341	CcSEcCtD
Pazopanib—Pain—Disulfiram—alcohol dependence	0.000768	0.00338	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.000766	0.00338	CcSEcCtD
Pazopanib—Pancreatitis—Acamprosate—alcohol dependence	0.000762	0.00336	CcSEcCtD
Pazopanib—Nasopharyngitis—Naltrexone—alcohol dependence	0.000761	0.00335	CcSEcCtD
Pazopanib—Musculoskeletal pain—Citalopram—alcohol dependence	0.000752	0.00331	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000751	0.00331	CcSEcCtD
Pazopanib—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.000743	0.00327	CcSEcCtD
Pazopanib—Pulmonary embolism—Citalopram—alcohol dependence	0.000743	0.00327	CcSEcCtD
Pazopanib—Hiccups—Citalopram—alcohol dependence	0.000743	0.00327	CcSEcCtD
Pazopanib—Blood pressure increased—Citalopram—alcohol dependence	0.000743	0.00327	CcSEcCtD
Pazopanib—Melaena—Citalopram—alcohol dependence	0.000726	0.0032	CcSEcCtD
Pazopanib—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00071	0.00313	CcSEcCtD
Pazopanib—Weight decreased—Acamprosate—alcohol dependence	0.000703	0.0031	CcSEcCtD
Pazopanib—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000683	0.00301	CcSEcCtD
Pazopanib—Myocardial infarction—Acamprosate—alcohol dependence	0.00068	0.003	CcSEcCtD
Pazopanib—Stomatitis—Acamprosate—alcohol dependence	0.000676	0.00298	CcSEcCtD
Pazopanib—Mouth ulceration—Citalopram—alcohol dependence	0.000672	0.00296	CcSEcCtD
Pazopanib—Weight decreased—Naltrexone—alcohol dependence	0.000666	0.00293	CcSEcCtD
Pazopanib—Haematuria—Acamprosate—alcohol dependence	0.000661	0.00291	CcSEcCtD
Pazopanib—Infestation NOS—Naltrexone—alcohol dependence	0.000656	0.00289	CcSEcCtD
Pazopanib—Infestation—Naltrexone—alcohol dependence	0.000656	0.00289	CcSEcCtD
Pazopanib—Epistaxis—Acamprosate—alcohol dependence	0.000654	0.00288	CcSEcCtD
Pazopanib—Acute coronary syndrome—Naltrexone—alcohol dependence	0.000647	0.00285	CcSEcCtD
Pazopanib—Asthenia—Disulfiram—alcohol dependence	0.000644	0.00284	CcSEcCtD
Pazopanib—Myocardial infarction—Naltrexone—alcohol dependence	0.000643	0.00283	CcSEcCtD
Pazopanib—Haemoglobin—Acamprosate—alcohol dependence	0.000625	0.00276	CcSEcCtD
Pazopanib—Haemorrhage—Acamprosate—alcohol dependence	0.000622	0.00274	CcSEcCtD
Pazopanib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00062	0.00273	CcSEcCtD
Pazopanib—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00062	0.00273	CcSEcCtD
Pazopanib—Hypoaesthesia—Acamprosate—alcohol dependence	0.000619	0.00273	CcSEcCtD
Pazopanib—Epistaxis—Naltrexone—alcohol dependence	0.000619	0.00273	CcSEcCtD
Pazopanib—Oedema peripheral—Acamprosate—alcohol dependence	0.000613	0.0027	CcSEcCtD
Pazopanib—Hepatic failure—Citalopram—alcohol dependence	0.0006	0.00264	CcSEcCtD
Pazopanib—Dizziness—Disulfiram—alcohol dependence	0.000594	0.00262	CcSEcCtD
Pazopanib—Connective tissue disorder—Naltrexone—alcohol dependence	0.000579	0.00255	CcSEcCtD
Pazopanib—Hot flush—Citalopram—alcohol dependence	0.000576	0.00254	CcSEcCtD
Pazopanib—RIOK2—cerebellum—alcohol dependence	0.000574	0.00318	CbGeAlD
Pazopanib—Menopausal symptoms—Citalopram—alcohol dependence	0.000572	0.00252	CcSEcCtD
Pazopanib—FGFR1—midbrain—alcohol dependence	0.000571	0.00317	CbGeAlD
Pazopanib—BMPR1B—cerebellum—alcohol dependence	0.000568	0.00315	CbGeAlD
Pazopanib—Rash—Disulfiram—alcohol dependence	0.000566	0.00249	CcSEcCtD
Pazopanib—LIMK2—endocrine gland—alcohol dependence	0.000566	0.00314	CbGeAlD
Pazopanib—CSF1R—forebrain—alcohol dependence	0.000562	0.00312	CbGeAlD
Pazopanib—Headache—Disulfiram—alcohol dependence	0.000562	0.00248	CcSEcCtD
Pazopanib—FLT1—pancreas—alcohol dependence	0.00056	0.00311	CbGeAlD
Pazopanib—Chills—Acamprosate—alcohol dependence	0.000558	0.00246	CcSEcCtD
Pazopanib—STK36—testis—alcohol dependence	0.000558	0.00309	CbGeAlD
Pazopanib—SH2B3—brain—alcohol dependence	0.000557	0.00309	CbGeAlD
Pazopanib—MAP3K2—blood—alcohol dependence	0.000553	0.00306	CbGeAlD
Pazopanib—Cardiac failure—Citalopram—alcohol dependence	0.000553	0.00244	CcSEcCtD
Pazopanib—Cerebrovascular accident—Citalopram—alcohol dependence	0.00055	0.00243	CcSEcCtD
Pazopanib—Lethargy—Citalopram—alcohol dependence	0.00055	0.00243	CcSEcCtD
Pazopanib—Eye disorder—Naltrexone—alcohol dependence	0.00055	0.00243	CcSEcCtD
Pazopanib—Alopecia—Acamprosate—alcohol dependence	0.00055	0.00242	CcSEcCtD
Pazopanib—PI4KB—testis—alcohol dependence	0.00055	0.00305	CbGeAlD
Pazopanib—AURKC—brain—alcohol dependence	0.000548	0.00304	CbGeAlD
Pazopanib—STK36—nervous system—alcohol dependence	0.000548	0.00304	CbGeAlD
Pazopanib—FGF1—digestive system—alcohol dependence	0.000547	0.00303	CbGeAlD
Pazopanib—Cardiac disorder—Naltrexone—alcohol dependence	0.000546	0.00241	CcSEcCtD
Pazopanib—STK10—cardiovascular system—alcohol dependence	0.000546	0.00303	CbGeAlD
Pazopanib—Mental disorder—Acamprosate—alcohol dependence	0.000545	0.0024	CcSEcCtD
Pazopanib—TAOK3—cardiovascular system—alcohol dependence	0.000544	0.00301	CbGeAlD
Pazopanib—Malnutrition—Acamprosate—alcohol dependence	0.000542	0.00239	CcSEcCtD
Pazopanib—Hyponatraemia—Citalopram—alcohol dependence	0.000541	0.00239	CcSEcCtD
Pazopanib—PDGFRA—cardiovascular system—alcohol dependence	0.00054	0.00299	CbGeAlD
Pazopanib—LIMK2—testis—alcohol dependence	0.00054	0.00299	CbGeAlD
Pazopanib—PI4KB—nervous system—alcohol dependence	0.00054	0.00299	CbGeAlD
Pazopanib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000539	0.00238	CcSEcCtD
Pazopanib—Angiopathy—Naltrexone—alcohol dependence	0.000534	0.00235	CcSEcCtD
Pazopanib—KDR—adrenal cortex—alcohol dependence	0.000534	0.00296	CbGeAlD
Pazopanib—MAP2K5—adrenal cortex—alcohol dependence	0.000534	0.00296	CbGeAlD
Pazopanib—Flatulence—Acamprosate—alcohol dependence	0.000534	0.00235	CcSEcCtD
Pazopanib—Mediastinal disorder—Naltrexone—alcohol dependence	0.000531	0.00234	CcSEcCtD
Pazopanib—Dysgeusia—Acamprosate—alcohol dependence	0.000531	0.00234	CcSEcCtD
Pazopanib—LIMK2—nervous system—alcohol dependence	0.00053	0.00294	CbGeAlD
Pazopanib—KIT—brainstem—alcohol dependence	0.000529	0.00293	CbGeAlD
Pazopanib—TAOK3—pancreas—alcohol dependence	0.000528	0.00293	CbGeAlD
Pazopanib—Chills—Naltrexone—alcohol dependence	0.000528	0.00233	CcSEcCtD
Pazopanib—STK36—liver—alcohol dependence	0.000528	0.00293	CbGeAlD
Pazopanib—STK36—central nervous system—alcohol dependence	0.000528	0.00292	CbGeAlD
Pazopanib—FLT1—gonad—alcohol dependence	0.000523	0.0029	CbGeAlD
Pazopanib—CSF1R—adrenal cortex—alcohol dependence	0.000521	0.00289	CbGeAlD
Pazopanib—Muscle spasms—Acamprosate—alcohol dependence	0.000521	0.0023	CcSEcCtD
Pazopanib—FGF1—blood—alcohol dependence	0.000521	0.00289	CbGeAlD
Pazopanib—Face oedema—Citalopram—alcohol dependence	0.000521	0.00229	CcSEcCtD
Pazopanib—Alopecia—Naltrexone—alcohol dependence	0.00052	0.00229	CcSEcCtD
Pazopanib—PI4KB—liver—alcohol dependence	0.00052	0.00288	CbGeAlD
Pazopanib—PI4KB—central nervous system—alcohol dependence	0.000519	0.00288	CbGeAlD
Pazopanib—LCK—blood—alcohol dependence	0.000518	0.00287	CbGeAlD
Pazopanib—FGFR2—digestive system—alcohol dependence	0.000516	0.00286	CbGeAlD
Pazopanib—Mental disorder—Naltrexone—alcohol dependence	0.000516	0.00227	CcSEcCtD
Pazopanib—STK36—cerebellum—alcohol dependence	0.000516	0.00286	CbGeAlD
Pazopanib—FGF1—midbrain—alcohol dependence	0.000514	0.00285	CbGeAlD
Pazopanib—Malnutrition—Naltrexone—alcohol dependence	0.000513	0.00226	CcSEcCtD
Pazopanib—LIMK2—liver—alcohol dependence	0.00051	0.00283	CbGeAlD
Pazopanib—LIMK2—central nervous system—alcohol dependence	0.00051	0.00283	CbGeAlD
Pazopanib—FLT4—endocrine gland—alcohol dependence	0.000509	0.00282	CbGeAlD
Pazopanib—PI4KB—cerebellum—alcohol dependence	0.000508	0.00281	CbGeAlD
Pazopanib—PIP4K2C—endocrine gland—alcohol dependence	0.000506	0.0028	CbGeAlD
Pazopanib—Flatulence—Naltrexone—alcohol dependence	0.000505	0.00223	CcSEcCtD
Pazopanib—Dysgeusia—Naltrexone—alcohol dependence	0.000502	0.00221	CcSEcCtD
Pazopanib—Dehydration—Citalopram—alcohol dependence	0.000502	0.00221	CcSEcCtD
Pazopanib—PLK4—brain—alcohol dependence	0.000502	0.00278	CbGeAlD
Pazopanib—Anaemia—Acamprosate—alcohol dependence	0.000501	0.00221	CcSEcCtD
Pazopanib—LIMK2—cerebellum—alcohol dependence	0.000498	0.00276	CbGeAlD
Pazopanib—Liver function test abnormal—Citalopram—alcohol dependence	0.000498	0.00219	CcSEcCtD
Pazopanib—STK10—gonad—alcohol dependence	0.000495	0.00275	CbGeAlD
Pazopanib—Dry skin—Citalopram—alcohol dependence	0.000494	0.00218	CcSEcCtD
Pazopanib—Muscle spasms—Naltrexone—alcohol dependence	0.000493	0.00217	CcSEcCtD
Pazopanib—Abdominal pain upper—Citalopram—alcohol dependence	0.000493	0.00217	CcSEcCtD
Pazopanib—FGFR2—blood—alcohol dependence	0.000492	0.00273	CbGeAlD
Pazopanib—PDGFRA—gonad—alcohol dependence	0.00049	0.00272	CbGeAlD
Pazopanib—Breast disorder—Citalopram—alcohol dependence	0.000487	0.00215	CcSEcCtD
Pazopanib—KDR—cardiovascular system—alcohol dependence	0.000487	0.0027	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—alcohol dependence	0.000487	0.0027	CbGeAlD
Pazopanib—Syncope—Acamprosate—alcohol dependence	0.000486	0.00214	CcSEcCtD
Pazopanib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000486	0.00214	CcSEcCtD
Pazopanib—FLT4—testis—alcohol dependence	0.000485	0.00269	CbGeAlD
Pazopanib—Leukopenia—Acamprosate—alcohol dependence	0.000485	0.00214	CcSEcCtD
Pazopanib—Vision blurred—Naltrexone—alcohol dependence	0.000483	0.00213	CcSEcCtD
Pazopanib—PIP4K2C—testis—alcohol dependence	0.000482	0.00267	CbGeAlD
Pazopanib—Nasopharyngitis—Citalopram—alcohol dependence	0.000482	0.00213	CcSEcCtD
Pazopanib—MAP3K2—endocrine gland—alcohol dependence	0.000479	0.00266	CbGeAlD
Pazopanib—FLT1—digestive system—alcohol dependence	0.000479	0.00265	CbGeAlD
Pazopanib—FGFR1—testis—alcohol dependence	0.000478	0.00265	CbGeAlD
Pazopanib—Loss of consciousness—Acamprosate—alcohol dependence	0.000476	0.0021	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000476	0.0021	CcSEcCtD
Pazopanib—CSF1R—cardiovascular system—alcohol dependence	0.000476	0.00264	CbGeAlD
Pazopanib—STK16—brain—alcohol dependence	0.000474	0.00263	CbGeAlD
Pazopanib—PIP4K2C—nervous system—alcohol dependence	0.000473	0.00262	CbGeAlD
Pazopanib—Cough—Acamprosate—alcohol dependence	0.000473	0.00208	CcSEcCtD
Pazopanib—Abdominal distension—Citalopram—alcohol dependence	0.000469	0.00207	CcSEcCtD
Pazopanib—LYN—brain—alcohol dependence	0.000469	0.0026	CbGeAlD
Pazopanib—Hypertension—Acamprosate—alcohol dependence	0.000468	0.00206	CcSEcCtD
Pazopanib—RIOK2—brain—alcohol dependence	0.000466	0.00258	CbGeAlD
Pazopanib—FGFR3—brain—alcohol dependence	0.000466	0.00258	CbGeAlD
Pazopanib—PDGFRB—adrenal cortex—alcohol dependence	0.000462	0.00256	CbGeAlD
Pazopanib—MAP3K19—brain—alcohol dependence	0.000462	0.00256	CbGeAlD
Pazopanib—BMPR1B—brain—alcohol dependence	0.000462	0.00256	CbGeAlD
Pazopanib—Chest pain—Acamprosate—alcohol dependence	0.000461	0.00203	CcSEcCtD
Pazopanib—Myalgia—Acamprosate—alcohol dependence	0.000461	0.00203	CcSEcCtD
Pazopanib—Arthralgia—Acamprosate—alcohol dependence	0.000461	0.00203	CcSEcCtD
Pazopanib—Syncope—Naltrexone—alcohol dependence	0.00046	0.00203	CcSEcCtD
Pazopanib—FLT4—liver—alcohol dependence	0.000459	0.00254	CbGeAlD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000458	0.00202	CcSEcCtD
Pazopanib—MAP3K2—testis—alcohol dependence	0.000457	0.00253	CbGeAlD
Pazopanib—Pancreatitis—Citalopram—alcohol dependence	0.000457	0.00201	CcSEcCtD
Pazopanib—PIP4K2C—liver—alcohol dependence	0.000456	0.00253	CbGeAlD
Pazopanib—FLT1—blood—alcohol dependence	0.000456	0.00253	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—alcohol dependence	0.000456	0.00253	CbGeAlD
Pazopanib—STK10—digestive system—alcohol dependence	0.000453	0.00251	CbGeAlD
Pazopanib—FGFR1—liver—alcohol dependence	0.000452	0.00251	CbGeAlD
Pazopanib—FGF1—endocrine gland—alcohol dependence	0.000452	0.0025	CbGeAlD
Pazopanib—TAOK3—digestive system—alcohol dependence	0.000451	0.0025	CbGeAlD
Pazopanib—Dry mouth—Acamprosate—alcohol dependence	0.000451	0.00199	CcSEcCtD
Pazopanib—EPHB6—blood—alcohol dependence	0.000451	0.0025	CbGeAlD
Pazopanib—Loss of consciousness—Naltrexone—alcohol dependence	0.000451	0.00199	CcSEcCtD
Pazopanib—FLT1—midbrain—alcohol dependence	0.00045	0.0025	CbGeAlD
Pazopanib—MAP3K2—nervous system—alcohol dependence	0.000449	0.00249	CbGeAlD
Pazopanib—PDGFRA—digestive system—alcohol dependence	0.000448	0.00249	CbGeAlD
Pazopanib—Cough—Naltrexone—alcohol dependence	0.000447	0.00197	CcSEcCtD
Pazopanib—PIP4K2C—cerebellum—alcohol dependence	0.000445	0.00247	CbGeAlD
Pazopanib—EPHB6—midbrain—alcohol dependence	0.000445	0.00247	CbGeAlD
Pazopanib—Hypertension—Naltrexone—alcohol dependence	0.000443	0.00195	CcSEcCtD
Pazopanib—FGFR1—cerebellum—alcohol dependence	0.000442	0.00245	CbGeAlD
Pazopanib—Infection—Acamprosate—alcohol dependence	0.000439	0.00194	CcSEcCtD
Pazopanib—Chest pain—Naltrexone—alcohol dependence	0.000436	0.00192	CcSEcCtD
Pazopanib—Arthralgia—Naltrexone—alcohol dependence	0.000436	0.00192	CcSEcCtD
Pazopanib—Myalgia—Naltrexone—alcohol dependence	0.000436	0.00192	CcSEcCtD
Pazopanib—Shock—Acamprosate—alcohol dependence	0.000435	0.00192	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000433	0.00191	CcSEcCtD
Pazopanib—Thrombocytopenia—Acamprosate—alcohol dependence	0.000433	0.00191	CcSEcCtD
Pazopanib—MAP3K2—liver—alcohol dependence	0.000432	0.0024	CbGeAlD
Pazopanib—MAP3K2—central nervous system—alcohol dependence	0.000432	0.0024	CbGeAlD
Pazopanib—KIT—cardiovascular system—alcohol dependence	0.000432	0.00239	CbGeAlD
Pazopanib—CSF1R—gonad—alcohol dependence	0.000432	0.00239	CbGeAlD
Pazopanib—STK10—blood—alcohol dependence	0.000432	0.00239	CbGeAlD
Pazopanib—FGF1—testis—alcohol dependence	0.000431	0.00239	CbGeAlD
Pazopanib—TAOK3—blood—alcohol dependence	0.00043	0.00238	CbGeAlD
Pazopanib—Skin disorder—Acamprosate—alcohol dependence	0.000429	0.00189	CcSEcCtD
Pazopanib—LCK—testis—alcohol dependence	0.000428	0.00237	CbGeAlD
Pazopanib—UGT1A1—digestive system—alcohol dependence	0.000428	0.00237	CbGeAlD
Pazopanib—Hyperhidrosis—Acamprosate—alcohol dependence	0.000427	0.00188	CcSEcCtD
Pazopanib—PDGFRA—blood—alcohol dependence	0.000427	0.00237	CbGeAlD
Pazopanib—Dry mouth—Naltrexone—alcohol dependence	0.000427	0.00188	CcSEcCtD
Pazopanib—FGFR2—endocrine gland—alcohol dependence	0.000427	0.00236	CbGeAlD
Pazopanib—Photosensitivity reaction—Citalopram—alcohol dependence	0.000425	0.00188	CcSEcCtD
Pazopanib—TAOK3—midbrain—alcohol dependence	0.000425	0.00235	CbGeAlD
Pazopanib—FGF1—nervous system—alcohol dependence	0.000423	0.00234	CbGeAlD
Pazopanib—MAP3K2—cerebellum—alcohol dependence	0.000422	0.00234	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—alcohol dependence	0.000422	0.00234	CbGeAlD
Pazopanib—Weight decreased—Citalopram—alcohol dependence	0.000422	0.00186	CcSEcCtD
Pazopanib—Anorexia—Acamprosate—alcohol dependence	0.000421	0.00186	CcSEcCtD
Pazopanib—KIT—pancreas—alcohol dependence	0.00042	0.00233	CbGeAlD
Pazopanib—STK36—brain—alcohol dependence	0.000419	0.00232	CbGeAlD
Pazopanib—Oedema—Naltrexone—alcohol dependence	0.000418	0.00184	CcSEcCtD
Pazopanib—Infection—Naltrexone—alcohol dependence	0.000416	0.00183	CcSEcCtD
Pazopanib—Infestation—Citalopram—alcohol dependence	0.000416	0.00183	CcSEcCtD
Pazopanib—Infestation NOS—Citalopram—alcohol dependence	0.000416	0.00183	CcSEcCtD
Pazopanib—PI4KB—brain—alcohol dependence	0.000412	0.00229	CbGeAlD
Pazopanib—Shock—Naltrexone—alcohol dependence	0.000412	0.00181	CcSEcCtD
Pazopanib—Nervous system disorder—Naltrexone—alcohol dependence	0.00041	0.00181	CcSEcCtD
Pazopanib—PDGFRB—pancreas—alcohol dependence	0.00041	0.00227	CbGeAlD
Pazopanib—Acute coronary syndrome—Citalopram—alcohol dependence	0.00041	0.00181	CcSEcCtD
Pazopanib—UGT1A1—blood—alcohol dependence	0.000408	0.00226	CbGeAlD
Pazopanib—Myocardial infarction—Citalopram—alcohol dependence	0.000407	0.0018	CcSEcCtD
Pazopanib—FGF1—liver—alcohol dependence	0.000407	0.00226	CbGeAlD
Pazopanib—FGF1—central nervous system—alcohol dependence	0.000407	0.00226	CbGeAlD
Pazopanib—FGFR2—testis—alcohol dependence	0.000407	0.00226	CbGeAlD
Pazopanib—Skin disorder—Naltrexone—alcohol dependence	0.000406	0.00179	CcSEcCtD
Pazopanib—Jaundice—Citalopram—alcohol dependence	0.000405	0.00179	CcSEcCtD
Pazopanib—Stomatitis—Citalopram—alcohol dependence	0.000405	0.00179	CcSEcCtD
Pazopanib—LIMK2—brain—alcohol dependence	0.000405	0.00224	CbGeAlD
Pazopanib—LCK—liver—alcohol dependence	0.000405	0.00224	CbGeAlD
Pazopanib—KDR—digestive system—alcohol dependence	0.000405	0.00224	CbGeAlD
Pazopanib—Hyperhidrosis—Naltrexone—alcohol dependence	0.000404	0.00178	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000403	0.00178	CcSEcCtD
Pazopanib—Insomnia—Acamprosate—alcohol dependence	0.0004	0.00176	CcSEcCtD
Pazopanib—FGFR2—nervous system—alcohol dependence	0.000399	0.00221	CbGeAlD
Pazopanib—Anorexia—Naltrexone—alcohol dependence	0.000399	0.00176	CcSEcCtD
Pazopanib—FGF1—cerebellum—alcohol dependence	0.000398	0.00221	CbGeAlD
Pazopanib—Paraesthesia—Acamprosate—alcohol dependence	0.000397	0.00175	CcSEcCtD
Pazopanib—Haematuria—Citalopram—alcohol dependence	0.000396	0.00175	CcSEcCtD
Pazopanib—FLT1—endocrine gland—alcohol dependence	0.000395	0.00219	CbGeAlD
Pazopanib—CSF1R—digestive system—alcohol dependence	0.000395	0.00219	CbGeAlD
Pazopanib—Dyspnoea—Acamprosate—alcohol dependence	0.000394	0.00174	CcSEcCtD
Pazopanib—Somnolence—Acamprosate—alcohol dependence	0.000393	0.00173	CcSEcCtD
Pazopanib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000393	0.00173	CcSEcCtD
Pazopanib—Epistaxis—Citalopram—alcohol dependence	0.000392	0.00173	CcSEcCtD
Pazopanib—KIT—gonad—alcohol dependence	0.000392	0.00217	CbGeAlD
Pazopanib—Dyspepsia—Acamprosate—alcohol dependence	0.000389	0.00172	CcSEcCtD
Pazopanib—KDR—blood—alcohol dependence	0.000385	0.00214	CbGeAlD
Pazopanib—MAP2K5—blood—alcohol dependence	0.000385	0.00214	CbGeAlD
Pazopanib—FGFR2—liver—alcohol dependence	0.000385	0.00213	CbGeAlD
Pazopanib—FGFR2—central nervous system—alcohol dependence	0.000384	0.00213	CbGeAlD
Pazopanib—Decreased appetite—Acamprosate—alcohol dependence	0.000384	0.00169	CcSEcCtD
Pazopanib—PDGFRB—gonad—alcohol dependence	0.000383	0.00212	CbGeAlD
Pazopanib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000382	0.00168	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000381	0.00168	CcSEcCtD
Pazopanib—KDR—midbrain—alcohol dependence	0.000381	0.00211	CbGeAlD
Pazopanib—MAP2K5—midbrain—alcohol dependence	0.000381	0.00211	CbGeAlD
Pazopanib—Bradycardia—Citalopram—alcohol dependence	0.00038	0.00167	CcSEcCtD
Pazopanib—Insomnia—Naltrexone—alcohol dependence	0.000378	0.00167	CcSEcCtD
Pazopanib—Pain—Acamprosate—alcohol dependence	0.000378	0.00167	CcSEcCtD
Pazopanib—FLT1—testis—alcohol dependence	0.000377	0.00209	CbGeAlD
Pazopanib—CSF1R—blood—alcohol dependence	0.000376	0.00208	CbGeAlD
Pazopanib—FGFR2—cerebellum—alcohol dependence	0.000376	0.00208	CbGeAlD
Pazopanib—Paraesthesia—Naltrexone—alcohol dependence	0.000376	0.00166	CcSEcCtD
Pazopanib—Haemoglobin—Citalopram—alcohol dependence	0.000375	0.00165	CcSEcCtD
Pazopanib—STK10—endocrine gland—alcohol dependence	0.000374	0.00207	CbGeAlD
Pazopanib—Haemorrhage—Citalopram—alcohol dependence	0.000373	0.00164	CcSEcCtD
Pazopanib—Dyspnoea—Naltrexone—alcohol dependence	0.000373	0.00164	CcSEcCtD
Pazopanib—TAOK3—endocrine gland—alcohol dependence	0.000373	0.00207	CbGeAlD
Pazopanib—EPHB6—testis—alcohol dependence	0.000373	0.00207	CbGeAlD
Pazopanib—Somnolence—Naltrexone—alcohol dependence	0.000372	0.00164	CcSEcCtD
Pazopanib—CSF1R—midbrain—alcohol dependence	0.000371	0.00206	CbGeAlD
Pazopanib—Hypoaesthesia—Citalopram—alcohol dependence	0.000371	0.00164	CcSEcCtD
Pazopanib—PDGFRA—endocrine gland—alcohol dependence	0.000371	0.00205	CbGeAlD
Pazopanib—FLT1—nervous system—alcohol dependence	0.00037	0.00205	CbGeAlD
Pazopanib—Urinary tract disorder—Citalopram—alcohol dependence	0.000368	0.00162	CcSEcCtD
Pazopanib—Oedema peripheral—Citalopram—alcohol dependence	0.000368	0.00162	CcSEcCtD
Pazopanib—Connective tissue disorder—Citalopram—alcohol dependence	0.000367	0.00162	CcSEcCtD
Pazopanib—EPHB6—nervous system—alcohol dependence	0.000366	0.00203	CbGeAlD
Pazopanib—Urethral disorder—Citalopram—alcohol dependence	0.000366	0.00161	CcSEcCtD
Pazopanib—FLT4—brain—alcohol dependence	0.000364	0.00202	CbGeAlD
Pazopanib—Decreased appetite—Naltrexone—alcohol dependence	0.000364	0.0016	CcSEcCtD
Pazopanib—PIP4K2C—brain—alcohol dependence	0.000362	0.00201	CbGeAlD
Pazopanib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000362	0.00159	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000361	0.00159	CcSEcCtD
Pazopanib—Fatigue—Naltrexone—alcohol dependence	0.000361	0.00159	CcSEcCtD
Pazopanib—FGFR1—brain—alcohol dependence	0.000359	0.00199	CbGeAlD
Pazopanib—KIT—digestive system—alcohol dependence	0.000358	0.00199	CbGeAlD
Pazopanib—Pain—Naltrexone—alcohol dependence	0.000358	0.00158	CcSEcCtD
Pazopanib—STK10—testis—alcohol dependence	0.000357	0.00198	CbGeAlD
Pazopanib—FLT1—liver—alcohol dependence	0.000357	0.00198	CbGeAlD
Pazopanib—FLT1—central nervous system—alcohol dependence	0.000356	0.00198	CbGeAlD
Pazopanib—SLCO1B1—digestive system—alcohol dependence	0.000356	0.00197	CbGeAlD
Pazopanib—TAOK3—testis—alcohol dependence	0.000356	0.00197	CbGeAlD
Pazopanib—UGT1A1—endocrine gland—alcohol dependence	0.000353	0.00196	CbGeAlD
Pazopanib—PDGFRA—testis—alcohol dependence	0.000353	0.00196	CbGeAlD
Pazopanib—EPHB6—central nervous system—alcohol dependence	0.000352	0.00195	CbGeAlD
Pazopanib—STK10—nervous system—alcohol dependence	0.00035	0.00194	CbGeAlD
Pazopanib—PDGFRB—digestive system—alcohol dependence	0.00035	0.00194	CbGeAlD
Pazopanib—Abdominal pain—Acamprosate—alcohol dependence	0.00035	0.00154	CcSEcCtD
Pazopanib—TAOK3—nervous system—alcohol dependence	0.000349	0.00193	CbGeAlD
Pazopanib—Eye disorder—Citalopram—alcohol dependence	0.000349	0.00154	CcSEcCtD
Pazopanib—FLT1—cerebellum—alcohol dependence	0.000348	0.00193	CbGeAlD
Pazopanib—PDGFRA—nervous system—alcohol dependence	0.000347	0.00192	CbGeAlD
Pazopanib—Flushing—Citalopram—alcohol dependence	0.000346	0.00153	CcSEcCtD
Pazopanib—Cardiac disorder—Citalopram—alcohol dependence	0.000346	0.00153	CcSEcCtD
Pazopanib—EPHB6—cerebellum—alcohol dependence	0.000344	0.00191	CbGeAlD
Pazopanib—MAP3K2—brain—alcohol dependence	0.000343	0.0019	CbGeAlD
Pazopanib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000342	0.00151	CcSEcCtD
Pazopanib—KIT—blood—alcohol dependence	0.000342	0.00189	CbGeAlD
Pazopanib—SLCO1B1—blood—alcohol dependence	0.000339	0.00188	CbGeAlD
Pazopanib—Angiopathy—Citalopram—alcohol dependence	0.000338	0.00149	CcSEcCtD
Pazopanib—STK10—liver—alcohol dependence	0.000337	0.00187	CbGeAlD
Pazopanib—STK10—central nervous system—alcohol dependence	0.000337	0.00187	CbGeAlD
Pazopanib—KIT—midbrain—alcohol dependence	0.000337	0.00187	CbGeAlD
Pazopanib—Mediastinal disorder—Citalopram—alcohol dependence	0.000336	0.00148	CcSEcCtD
Pazopanib—TAOK3—liver—alcohol dependence	0.000336	0.00186	CbGeAlD
Pazopanib—TAOK3—central nervous system—alcohol dependence	0.000336	0.00186	CbGeAlD
Pazopanib—Chills—Citalopram—alcohol dependence	0.000335	0.00148	CcSEcCtD
Pazopanib—KDR—endocrine gland—alcohol dependence	0.000334	0.00185	CbGeAlD
Pazopanib—MAP2K5—endocrine gland—alcohol dependence	0.000334	0.00185	CbGeAlD
Pazopanib—PDGFRA—liver—alcohol dependence	0.000334	0.00185	CbGeAlD
Pazopanib—PDGFRA—central nervous system—alcohol dependence	0.000334	0.00185	CbGeAlD
Pazopanib—PDGFRB—blood—alcohol dependence	0.000334	0.00185	CbGeAlD
Pazopanib—Abdominal pain—Naltrexone—alcohol dependence	0.000331	0.00146	CcSEcCtD
Pazopanib—STK10—cerebellum—alcohol dependence	0.00033	0.00183	CbGeAlD
Pazopanib—Alopecia—Citalopram—alcohol dependence	0.00033	0.00145	CcSEcCtD
Pazopanib—PDGFRB—midbrain—alcohol dependence	0.000329	0.00183	CbGeAlD
Pazopanib—TAOK3—cerebellum—alcohol dependence	0.000328	0.00182	CbGeAlD
Pazopanib—Mental disorder—Citalopram—alcohol dependence	0.000327	0.00144	CcSEcCtD
Pazopanib—PDGFRA—cerebellum—alcohol dependence	0.000326	0.00181	CbGeAlD
Pazopanib—CSF1R—endocrine gland—alcohol dependence	0.000326	0.00181	CbGeAlD
Pazopanib—Erythema—Citalopram—alcohol dependence	0.000325	0.00143	CcSEcCtD
Pazopanib—Malnutrition—Citalopram—alcohol dependence	0.000325	0.00143	CcSEcCtD
Pazopanib—FGF1—brain—alcohol dependence	0.000323	0.00179	CbGeAlD
Pazopanib—Flatulence—Citalopram—alcohol dependence	0.00032	0.00141	CcSEcCtD
Pazopanib—KDR—testis—alcohol dependence	0.000319	0.00177	CbGeAlD
Pazopanib—MAP2K5—testis—alcohol dependence	0.000319	0.00177	CbGeAlD
Pazopanib—UGT1A1—liver—alcohol dependence	0.000319	0.00177	CbGeAlD
Pazopanib—Dysgeusia—Citalopram—alcohol dependence	0.000318	0.0014	CcSEcCtD
Pazopanib—Asthenia—Acamprosate—alcohol dependence	0.000317	0.0014	CcSEcCtD
Pazopanib—KDR—nervous system—alcohol dependence	0.000313	0.00173	CbGeAlD
Pazopanib—MAP2K5—nervous system—alcohol dependence	0.000313	0.00173	CbGeAlD
Pazopanib—Pruritus—Acamprosate—alcohol dependence	0.000313	0.00138	CcSEcCtD
Pazopanib—Muscle spasms—Citalopram—alcohol dependence	0.000312	0.00138	CcSEcCtD
Pazopanib—CSF1R—testis—alcohol dependence	0.000311	0.00172	CbGeAlD
Pazopanib—Vision blurred—Citalopram—alcohol dependence	0.000306	0.00135	CcSEcCtD
Pazopanib—CSF1R—nervous system—alcohol dependence	0.000305	0.00169	CbGeAlD
Pazopanib—FGFR2—brain—alcohol dependence	0.000305	0.00169	CbGeAlD
Pazopanib—Diarrhoea—Acamprosate—alcohol dependence	0.000303	0.00133	CcSEcCtD
Pazopanib—KDR—liver—alcohol dependence	0.000301	0.00167	CbGeAlD
Pazopanib—MAP2K5—liver—alcohol dependence	0.000301	0.00167	CbGeAlD
Pazopanib—KDR—central nervous system—alcohol dependence	0.000301	0.00167	CbGeAlD
Pazopanib—MAP2K5—central nervous system—alcohol dependence	0.000301	0.00167	CbGeAlD
Pazopanib—Anaemia—Citalopram—alcohol dependence	0.0003	0.00132	CcSEcCtD
Pazopanib—Asthenia—Naltrexone—alcohol dependence	0.0003	0.00132	CcSEcCtD
Pazopanib—KIT—endocrine gland—alcohol dependence	0.000296	0.00164	CbGeAlD
Pazopanib—Pruritus—Naltrexone—alcohol dependence	0.000296	0.0013	CcSEcCtD
Pazopanib—KDR—cerebellum—alcohol dependence	0.000294	0.00163	CbGeAlD
Pazopanib—MAP2K5—cerebellum—alcohol dependence	0.000294	0.00163	CbGeAlD
Pazopanib—SLCO1B1—endocrine gland—alcohol dependence	0.000294	0.00163	CbGeAlD
Pazopanib—CSF1R—liver—alcohol dependence	0.000294	0.00163	CbGeAlD
Pazopanib—CSF1R—central nervous system—alcohol dependence	0.000294	0.00163	CbGeAlD
Pazopanib—Dizziness—Acamprosate—alcohol dependence	0.000292	0.00129	CcSEcCtD
Pazopanib—Syncope—Citalopram—alcohol dependence	0.000291	0.00128	CcSEcCtD
Pazopanib—Leukopenia—Citalopram—alcohol dependence	0.000291	0.00128	CcSEcCtD
Pazopanib—PDGFRB—endocrine gland—alcohol dependence	0.000289	0.0016	CbGeAlD
Pazopanib—CSF1R—cerebellum—alcohol dependence	0.000287	0.00159	CbGeAlD
Pazopanib—Diarrhoea—Naltrexone—alcohol dependence	0.000286	0.00126	CcSEcCtD
Pazopanib—Loss of consciousness—Citalopram—alcohol dependence	0.000285	0.00126	CcSEcCtD
Pazopanib—Cough—Citalopram—alcohol dependence	0.000283	0.00125	CcSEcCtD
Pazopanib—FLT1—brain—alcohol dependence	0.000283	0.00157	CbGeAlD
Pazopanib—KIT—testis—alcohol dependence	0.000282	0.00157	CbGeAlD
Pazopanib—Vomiting—Acamprosate—alcohol dependence	0.000281	0.00124	CcSEcCtD
Pazopanib—Hypertension—Citalopram—alcohol dependence	0.00028	0.00124	CcSEcCtD
Pazopanib—EPHB6—brain—alcohol dependence	0.00028	0.00155	CbGeAlD
Pazopanib—Rash—Acamprosate—alcohol dependence	0.000279	0.00123	CcSEcCtD
Pazopanib—Dermatitis—Acamprosate—alcohol dependence	0.000279	0.00123	CcSEcCtD
Pazopanib—KIT—nervous system—alcohol dependence	0.000277	0.00154	CbGeAlD
Pazopanib—Headache—Acamprosate—alcohol dependence	0.000277	0.00122	CcSEcCtD
Pazopanib—Dizziness—Naltrexone—alcohol dependence	0.000277	0.00122	CcSEcCtD
Pazopanib—Arthralgia—Citalopram—alcohol dependence	0.000276	0.00122	CcSEcCtD
Pazopanib—Chest pain—Citalopram—alcohol dependence	0.000276	0.00122	CcSEcCtD
Pazopanib—Myalgia—Citalopram—alcohol dependence	0.000276	0.00122	CcSEcCtD
Pazopanib—PDGFRB—testis—alcohol dependence	0.000276	0.00153	CbGeAlD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000275	0.00121	CcSEcCtD
Pazopanib—PDGFRB—nervous system—alcohol dependence	0.000271	0.0015	CbGeAlD
Pazopanib—Dry mouth—Citalopram—alcohol dependence	0.00027	0.00119	CcSEcCtD
Pazopanib—STK10—brain—alcohol dependence	0.000268	0.00148	CbGeAlD
Pazopanib—KIT—liver—alcohol dependence	0.000267	0.00148	CbGeAlD
Pazopanib—KIT—central nervous system—alcohol dependence	0.000267	0.00148	CbGeAlD
Pazopanib—TAOK3—brain—alcohol dependence	0.000267	0.00148	CbGeAlD
Pazopanib—Vomiting—Naltrexone—alcohol dependence	0.000266	0.00117	CcSEcCtD
Pazopanib—SLCO1B1—liver—alcohol dependence	0.000265	0.00147	CbGeAlD
Pazopanib—PDGFRA—brain—alcohol dependence	0.000265	0.00147	CbGeAlD
Pazopanib—Oedema—Citalopram—alcohol dependence	0.000265	0.00117	CcSEcCtD
Pazopanib—Rash—Naltrexone—alcohol dependence	0.000264	0.00116	CcSEcCtD
Pazopanib—Dermatitis—Naltrexone—alcohol dependence	0.000264	0.00116	CcSEcCtD
Pazopanib—Infection—Citalopram—alcohol dependence	0.000263	0.00116	CcSEcCtD
Pazopanib—Nausea—Acamprosate—alcohol dependence	0.000263	0.00116	CcSEcCtD
Pazopanib—Headache—Naltrexone—alcohol dependence	0.000262	0.00116	CcSEcCtD
Pazopanib—KIT—cerebellum—alcohol dependence	0.000261	0.00145	CbGeAlD
Pazopanib—PDGFRB—liver—alcohol dependence	0.000261	0.00145	CbGeAlD
Pazopanib—Shock—Citalopram—alcohol dependence	0.000261	0.00115	CcSEcCtD
Pazopanib—PDGFRB—central nervous system—alcohol dependence	0.000261	0.00145	CbGeAlD
Pazopanib—Nervous system disorder—Citalopram—alcohol dependence	0.00026	0.00115	CcSEcCtD
Pazopanib—ABCG2—adrenal cortex—alcohol dependence	0.00026	0.00144	CbGeAlD
Pazopanib—Thrombocytopenia—Citalopram—alcohol dependence	0.00026	0.00114	CcSEcCtD
Pazopanib—Skin disorder—Citalopram—alcohol dependence	0.000257	0.00113	CcSEcCtD
Pazopanib—Hyperhidrosis—Citalopram—alcohol dependence	0.000256	0.00113	CcSEcCtD
Pazopanib—PDGFRB—cerebellum—alcohol dependence	0.000255	0.00141	CbGeAlD
Pazopanib—Anorexia—Citalopram—alcohol dependence	0.000253	0.00111	CcSEcCtD
Pazopanib—Nausea—Naltrexone—alcohol dependence	0.000248	0.0011	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000241	0.00106	CcSEcCtD
Pazopanib—Insomnia—Citalopram—alcohol dependence	0.00024	0.00106	CcSEcCtD
Pazopanib—KDR—brain—alcohol dependence	0.000239	0.00133	CbGeAlD
Pazopanib—MAP2K5—brain—alcohol dependence	0.000239	0.00133	CbGeAlD
Pazopanib—Paraesthesia—Citalopram—alcohol dependence	0.000238	0.00105	CcSEcCtD
Pazopanib—Dyspnoea—Citalopram—alcohol dependence	0.000236	0.00104	CcSEcCtD
Pazopanib—Somnolence—Citalopram—alcohol dependence	0.000236	0.00104	CcSEcCtD
Pazopanib—CSF1R—brain—alcohol dependence	0.000233	0.00129	CbGeAlD
Pazopanib—Dyspepsia—Citalopram—alcohol dependence	0.000233	0.00103	CcSEcCtD
Pazopanib—Decreased appetite—Citalopram—alcohol dependence	0.00023	0.00102	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000229	0.00101	CcSEcCtD
Pazopanib—Fatigue—Citalopram—alcohol dependence	0.000229	0.00101	CcSEcCtD
Pazopanib—Pain—Citalopram—alcohol dependence	0.000227	0.000999	CcSEcCtD
Pazopanib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000217	0.000955	CcSEcCtD
Pazopanib—KIT—brain—alcohol dependence	0.000212	0.00117	CbGeAlD
Pazopanib—Abdominal pain—Citalopram—alcohol dependence	0.00021	0.000924	CcSEcCtD
Pazopanib—PDGFRB—brain—alcohol dependence	0.000207	0.00115	CbGeAlD
Pazopanib—CYP2D6—brainstem—alcohol dependence	0.000199	0.0011	CbGeAlD
Pazopanib—CYP2C8—blood—alcohol dependence	0.000193	0.00107	CbGeAlD
Pazopanib—CYP2D6—forebrain—alcohol dependence	0.000192	0.00107	CbGeAlD
Pazopanib—Asthenia—Citalopram—alcohol dependence	0.00019	0.000838	CcSEcCtD
Pazopanib—CYP1A2—digestive system—alcohol dependence	0.000189	0.00105	CbGeAlD
Pazopanib—Pruritus—Citalopram—alcohol dependence	0.000188	0.000827	CcSEcCtD
Pazopanib—ABCG2—blood—alcohol dependence	0.000187	0.00104	CbGeAlD
Pazopanib—ABCG2—midbrain—alcohol dependence	0.000185	0.00103	CbGeAlD
Pazopanib—Diarrhoea—Citalopram—alcohol dependence	0.000181	0.000799	CcSEcCtD
Pazopanib—CYP1A2—blood—alcohol dependence	0.00018	0.001	CbGeAlD
Pazopanib—Dizziness—Citalopram—alcohol dependence	0.000175	0.000773	CcSEcCtD
Pazopanib—Vomiting—Citalopram—alcohol dependence	0.000169	0.000743	CcSEcCtD
Pazopanib—CYP2C8—endocrine gland—alcohol dependence	0.000167	0.000927	CbGeAlD
Pazopanib—Rash—Citalopram—alcohol dependence	0.000167	0.000737	CcSEcCtD
Pazopanib—Dermatitis—Citalopram—alcohol dependence	0.000167	0.000736	CcSEcCtD
Pazopanib—Headache—Citalopram—alcohol dependence	0.000166	0.000732	CcSEcCtD
Pazopanib—CYP2C8—testis—alcohol dependence	0.000159	0.000884	CbGeAlD
Pazopanib—Nausea—Citalopram—alcohol dependence	0.000157	0.000694	CcSEcCtD
Pazopanib—CYP1A2—endocrine gland—alcohol dependence	0.000157	0.000868	CbGeAlD
Pazopanib—ABCG2—testis—alcohol dependence	0.000155	0.00086	CbGeAlD
Pazopanib—CYP2C8—liver—alcohol dependence	0.000151	0.000836	CbGeAlD
Pazopanib—ABCG2—liver—alcohol dependence	0.000147	0.000813	CbGeAlD
Pazopanib—ABCG2—cerebellum—alcohol dependence	0.000143	0.000794	CbGeAlD
Pazopanib—CYP1A2—liver—alcohol dependence	0.000141	0.000782	CbGeAlD
Pazopanib—ABCB1—forebrain—alcohol dependence	0.000138	0.000766	CbGeAlD
Pazopanib—CYP3A4—digestive system—alcohol dependence	0.000137	0.00076	CbGeAlD
Pazopanib—CYP2D6—digestive system—alcohol dependence	0.000135	0.000748	CbGeAlD
Pazopanib—CYP3A4—blood—alcohol dependence	0.000131	0.000724	CbGeAlD
Pazopanib—CYP2D6—blood—alcohol dependence	0.000129	0.000712	CbGeAlD
Pazopanib—ABCB1—adrenal cortex—alcohol dependence	0.000128	0.00071	CbGeAlD
Pazopanib—CYP2C8—brain—alcohol dependence	0.00012	0.000663	CbGeAlD
Pazopanib—ABCB1—cardiovascular system—alcohol dependence	0.000117	0.000648	CbGeAlD
Pazopanib—ABCG2—brain—alcohol dependence	0.000116	0.000645	CbGeAlD
Pazopanib—ABCB1—pancreas—alcohol dependence	0.000114	0.00063	CbGeAlD
Pazopanib—CYP3A4—endocrine gland—alcohol dependence	0.000113	0.000628	CbGeAlD
Pazopanib—CYP2D6—endocrine gland—alcohol dependence	0.000111	0.000618	CbGeAlD
Pazopanib—CYP2D6—testis—alcohol dependence	0.000106	0.000589	CbGeAlD
Pazopanib—ABCB1—gonad—alcohol dependence	0.000106	0.000588	CbGeAlD
Pazopanib—CYP3A4—nervous system—alcohol dependence	0.000106	0.000588	CbGeAlD
Pazopanib—CYP2D6—nervous system—alcohol dependence	0.000104	0.000578	CbGeAlD
Pazopanib—CYP3A4—liver—alcohol dependence	0.000102	0.000566	CbGeAlD
Pazopanib—CYP3A4—central nervous system—alcohol dependence	0.000102	0.000566	CbGeAlD
Pazopanib—CYP2D6—liver—alcohol dependence	0.000101	0.000557	CbGeAlD
Pazopanib—CYP2D6—central nervous system—alcohol dependence	0.0001	0.000557	CbGeAlD
Pazopanib—CYP2D6—cerebellum—alcohol dependence	9.82e-05	0.000544	CbGeAlD
Pazopanib—ABCB1—digestive system—alcohol dependence	9.7e-05	0.000538	CbGeAlD
Pazopanib—ABCB1—blood—alcohol dependence	9.25e-05	0.000513	CbGeAlD
Pazopanib—ABCB1—midbrain—alcohol dependence	9.13e-05	0.000506	CbGeAlD
Pazopanib—ABCB1—endocrine gland—alcohol dependence	8.02e-05	0.000445	CbGeAlD
Pazopanib—CYP2D6—brain—alcohol dependence	7.98e-05	0.000442	CbGeAlD
Pazopanib—ABCB1—testis—alcohol dependence	7.65e-05	0.000424	CbGeAlD
Pazopanib—ABCB1—nervous system—alcohol dependence	7.51e-05	0.000416	CbGeAlD
Pazopanib—ABCB1—liver—alcohol dependence	7.23e-05	0.000401	CbGeAlD
Pazopanib—ABCB1—central nervous system—alcohol dependence	7.23e-05	0.000401	CbGeAlD
Pazopanib—ABCB1—cerebellum—alcohol dependence	7.06e-05	0.000392	CbGeAlD
Pazopanib—ABCB1—brain—alcohol dependence	5.74e-05	0.000318	CbGeAlD
Pazopanib—KIT—Signaling Pathways—NPY—alcohol dependence	2.84e-05	0.000266	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CNR1—alcohol dependence	2.81e-05	0.000264	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CHRM2—alcohol dependence	2.8e-05	0.000263	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADH1A—alcohol dependence	2.79e-05	0.000262	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR1B—alcohol dependence	2.79e-05	0.000262	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CRH—alcohol dependence	2.79e-05	0.000262	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—AVP—alcohol dependence	2.78e-05	0.000261	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HTR7—alcohol dependence	2.74e-05	0.000257	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—OPRD1—alcohol dependence	2.74e-05	0.000257	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD2—alcohol dependence	2.74e-05	0.000257	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR1B—alcohol dependence	2.74e-05	0.000257	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CRH—alcohol dependence	2.74e-05	0.000257	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADH4—alcohol dependence	2.73e-05	0.000256	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALDH2—alcohol dependence	2.72e-05	0.000255	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MAOB—alcohol dependence	2.71e-05	0.000255	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—EP300—alcohol dependence	2.7e-05	0.000254	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NPY—alcohol dependence	2.69e-05	0.000253	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH6—alcohol dependence	2.69e-05	0.000253	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NPY—alcohol dependence	2.68e-05	0.000252	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADH1A—alcohol dependence	2.63e-05	0.000247	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PDYN—alcohol dependence	2.63e-05	0.000247	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—OPRM1—alcohol dependence	2.63e-05	0.000247	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—GOT1—alcohol dependence	2.6e-05	0.000244	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR1B—alcohol dependence	2.6e-05	0.000244	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CRH—alcohol dependence	2.6e-05	0.000244	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CRH—alcohol dependence	2.59e-05	0.000243	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR1B—alcohol dependence	2.59e-05	0.000243	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—OPRM1—alcohol dependence	2.57e-05	0.000242	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—POMC—alcohol dependence	2.49e-05	0.000234	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALDH2—alcohol dependence	2.49e-05	0.000234	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—AVP—alcohol dependence	2.48e-05	0.000233	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—WASF2—alcohol dependence	2.44e-05	0.000229	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CRHR1—alcohol dependence	2.44e-05	0.000229	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD4—alcohol dependence	2.43e-05	0.000229	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—AVP—alcohol dependence	2.42e-05	0.000227	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NPY—alcohol dependence	2.42e-05	0.000227	CbGpPWpGaD
Pazopanib—LCK—Disease—GOT2—alcohol dependence	2.42e-05	0.000227	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—POMC—alcohol dependence	2.41e-05	0.000227	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.4e-05	0.000225	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD4—alcohol dependence	2.39e-05	0.000225	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADH4—alcohol dependence	2.37e-05	0.000223	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NPY—alcohol dependence	2.37e-05	0.000222	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.36e-05	0.000222	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—EP300—alcohol dependence	2.36e-05	0.000222	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—EP300—alcohol dependence	2.35e-05	0.000221	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—WASF1—alcohol dependence	2.34e-05	0.00022	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR1B—alcohol dependence	2.33e-05	0.000219	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CRH—alcohol dependence	2.33e-05	0.000219	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CNR1—alcohol dependence	2.32e-05	0.000218	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADH7—alcohol dependence	2.32e-05	0.000218	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GOT2—alcohol dependence	2.31e-05	0.000217	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HTR2A—alcohol dependence	2.31e-05	0.000217	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALDH2—alcohol dependence	2.31e-05	0.000217	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—AVP—alcohol dependence	2.31e-05	0.000217	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CHRM2—alcohol dependence	2.3e-05	0.000216	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR1B—alcohol dependence	2.28e-05	0.000215	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CRH—alcohol dependence	2.28e-05	0.000215	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CNR1—alcohol dependence	2.28e-05	0.000214	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD4—alcohol dependence	2.27e-05	0.000213	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD2—alcohol dependence	2.27e-05	0.000213	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR7—alcohol dependence	2.27e-05	0.000213	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD4—alcohol dependence	2.26e-05	0.000213	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADH4—alcohol dependence	2.24e-05	0.00021	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—EP300—alcohol dependence	2.23e-05	0.00021	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH1A—alcohol dependence	2.23e-05	0.000209	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR7—alcohol dependence	2.23e-05	0.000209	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD2—alcohol dependence	2.23e-05	0.000209	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GGT2—alcohol dependence	2.22e-05	0.000209	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—EP300—alcohol dependence	2.19e-05	0.000206	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CYP2E1—alcohol dependence	2.17e-05	0.000204	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CNR1—alcohol dependence	2.17e-05	0.000204	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CNR1—alcohol dependence	2.16e-05	0.000203	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—EP300—alcohol dependence	2.15e-05	0.000202	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GOT2—alcohol dependence	2.12e-05	0.000199	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD2—alcohol dependence	2.11e-05	0.000199	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR7—alcohol dependence	2.11e-05	0.000199	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD2—alcohol dependence	2.11e-05	0.000198	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR7—alcohol dependence	2.11e-05	0.000198	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—OPRM1—alcohol dependence	2.11e-05	0.000198	CbGpPWpGaD
Pazopanib—LCK—Disease—GOT1—alcohol dependence	2.09e-05	0.000196	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—EP300—alcohol dependence	2.08e-05	0.000196	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—EP300—alcohol dependence	2.08e-05	0.000195	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH6—alcohol dependence	2.08e-05	0.000195	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—EP300—alcohol dependence	2.07e-05	0.000195	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.07e-05	0.000195	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HTR2A—alcohol dependence	2.06e-05	0.000194	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD4—alcohol dependence	2.04e-05	0.000192	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—EP300—alcohol dependence	2.04e-05	0.000191	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADH1B—alcohol dependence	2.03e-05	0.000191	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADH7—alcohol dependence	2.02e-05	0.00019	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HTR2A—alcohol dependence	2.01e-05	0.000189	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD4—alcohol dependence	2e-05	0.000188	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GGT1—alcohol dependence	2e-05	0.000187	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—GOT1—alcohol dependence	2e-05	0.000187	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CYP2E1—alcohol dependence	1.99e-05	0.000187	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GOT2—alcohol dependence	1.96e-05	0.000184	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CNR1—alcohol dependence	1.95e-05	0.000183	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NPY—alcohol dependence	1.94e-05	0.000182	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GGT2—alcohol dependence	1.94e-05	0.000182	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—POMC—alcohol dependence	1.92e-05	0.000181	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HTR2A—alcohol dependence	1.92e-05	0.00018	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—AVP—alcohol dependence	1.91e-05	0.000179	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CNR1—alcohol dependence	1.91e-05	0.000179	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	1.91e-05	0.000179	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADH7—alcohol dependence	1.9e-05	0.000179	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR7—alcohol dependence	1.9e-05	0.000178	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD2—alcohol dependence	1.9e-05	0.000178	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH4—alcohol dependence	1.9e-05	0.000178	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—EP300—alcohol dependence	1.89e-05	0.000178	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—AVP—alcohol dependence	1.87e-05	0.000176	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR1B—alcohol dependence	1.87e-05	0.000176	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CRH—alcohol dependence	1.87e-05	0.000176	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—EP300—alcohol dependence	1.87e-05	0.000176	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR7—alcohol dependence	1.86e-05	0.000175	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD2—alcohol dependence	1.86e-05	0.000175	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—POMC—alcohol dependence	1.84e-05	0.000173	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CYP2E1—alcohol dependence	1.84e-05	0.000173	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—EP300—alcohol dependence	1.83e-05	0.000172	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GGT1—alcohol dependence	1.83e-05	0.000172	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—GOT1—alcohol dependence	1.83e-05	0.000172	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GGT2—alcohol dependence	1.82e-05	0.000171	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—MAOA—alcohol dependence	1.79e-05	0.000168	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—AVP—alcohol dependence	1.78e-05	0.000167	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—AVP—alcohol dependence	1.77e-05	0.000167	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.77e-05	0.000166	CbGpPWpGaD
Pazopanib—FGFR3—Disease—EP300—alcohol dependence	1.75e-05	0.000164	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.72e-05	0.000162	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.72e-05	0.000161	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GOT1—alcohol dependence	1.69e-05	0.000159	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—GGT1—alcohol dependence	1.69e-05	0.000159	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOB—alcohol dependence	1.68e-05	0.000158	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—EP300—alcohol dependence	1.67e-05	0.000157	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.67e-05	0.000157	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—POMC—alcohol dependence	1.65e-05	0.000155	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	1.64e-05	0.000154	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MAOA—alcohol dependence	1.64e-05	0.000154	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD4—alcohol dependence	1.64e-05	0.000154	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH7—alcohol dependence	1.61e-05	0.000151	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—POMC—alcohol dependence	1.61e-05	0.000151	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—EP300—alcohol dependence	1.6e-05	0.00015	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—AVP—alcohol dependence	1.6e-05	0.00015	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.59e-05	0.000149	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR2A—alcohol dependence	1.59e-05	0.000149	CbGpPWpGaD
Pazopanib—FGF1—Immune System—EP300—alcohol dependence	1.57e-05	0.000148	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—AVP—alcohol dependence	1.57e-05	0.000147	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CNR1—alcohol dependence	1.56e-05	0.000147	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR2A—alcohol dependence	1.56e-05	0.000147	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGT2—alcohol dependence	1.55e-05	0.000145	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—POMC—alcohol dependence	1.53e-05	0.000144	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR7—alcohol dependence	1.52e-05	0.000143	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD2—alcohol dependence	1.52e-05	0.000143	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MAOA—alcohol dependence	1.52e-05	0.000143	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—EP300—alcohol dependence	1.5e-05	0.000141	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR2A—alcohol dependence	1.48e-05	0.000139	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR2A—alcohol dependence	1.48e-05	0.000139	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOB—alcohol dependence	1.47e-05	0.000138	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.46e-05	0.000137	CbGpPWpGaD
Pazopanib—FGF1—Disease—EP300—alcohol dependence	1.45e-05	0.000136	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALDH2—alcohol dependence	1.43e-05	0.000134	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADH1B—alcohol dependence	1.41e-05	0.000133	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOB—alcohol dependence	1.38e-05	0.00013	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.38e-05	0.000129	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR2A—alcohol dependence	1.33e-05	0.000125	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR2A—alcohol dependence	1.3e-05	0.000122	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—EP300—alcohol dependence	1.3e-05	0.000122	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—AVP—alcohol dependence	1.28e-05	0.000121	CbGpPWpGaD
Pazopanib—KIT—Immune System—EP300—alcohol dependence	1.28e-05	0.00012	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—POMC—alcohol dependence	1.27e-05	0.000119	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.25e-05	0.000117	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—POMC—alcohol dependence	1.25e-05	0.000117	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.24e-05	0.000117	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EP300—alcohol dependence	1.22e-05	0.000115	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT2—alcohol dependence	1.22e-05	0.000114	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EP300—alcohol dependence	1.21e-05	0.000114	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EP300—alcohol dependence	1.21e-05	0.000114	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EP300—alcohol dependence	1.2e-05	0.000113	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.19e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—POMC—alcohol dependence	1.18e-05	0.000111	CbGpPWpGaD
Pazopanib—KIT—Disease—EP300—alcohol dependence	1.18e-05	0.000111	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—POMC—alcohol dependence	1.18e-05	0.000111	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.18e-05	0.00011	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOB—alcohol dependence	1.17e-05	0.00011	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—POMC—alcohol dependence	1.16e-05	0.000109	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CYP2E1—alcohol dependence	1.14e-05	0.000108	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EP300—alcohol dependence	1.12e-05	0.000105	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EP300—alcohol dependence	1.12e-05	0.000105	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EP300—alcohol dependence	1.09e-05	0.000103	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.09e-05	0.000102	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EP300—alcohol dependence	1.09e-05	0.000102	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—alcohol dependence	1.07e-05	0.0001	CbGpPWpGaD
Pazopanib—LYN—Immune System—EP300—alcohol dependence	1.07e-05	0.0001	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—alcohol dependence	1.07e-05	0.0001	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EP300—alcohol dependence	1.07e-05	0.0001	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—alcohol dependence	1.06e-05	9.98e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT2—alcohol dependence	1.06e-05	9.96e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GGT1—alcohol dependence	1.05e-05	9.87e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GOT1—alcohol dependence	1.05e-05	9.87e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—alcohol dependence	1.04e-05	9.77e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EP300—alcohol dependence	1.02e-05	9.55e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EP300—alcohol dependence	1.01e-05	9.46e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT2—alcohol dependence	9.99e-06	9.39e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CYP2E1—alcohol dependence	9.97e-06	9.37e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALDH2—alcohol dependence	9.96e-06	9.35e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—alcohol dependence	9.88e-06	9.28e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	9.57e-06	8.99e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOA—alcohol dependence	9.42e-06	8.85e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	9.4e-06	8.83e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GOT1—alcohol dependence	9.15e-06	8.6e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GGT1—alcohol dependence	9.15e-06	8.6e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.13e-06	8.58e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOB—alcohol dependence	9.04e-06	8.49e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—EP300—alcohol dependence	8.75e-06	8.22e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GGT1—alcohol dependence	8.63e-06	8.1e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GOT1—alcohol dependence	8.63e-06	8.1e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—alcohol dependence	8.53e-06	8.01e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT2—alcohol dependence	8.47e-06	7.95e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EP300—alcohol dependence	8.42e-06	7.91e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EP300—alcohol dependence	8.26e-06	7.76e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOA—alcohol dependence	8.2e-06	7.71e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—EP300—alcohol dependence	8.08e-06	7.59e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CYP2E1—alcohol dependence	7.96e-06	7.48e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EP300—alcohol dependence	7.84e-06	7.37e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EP300—alcohol dependence	7.82e-06	7.35e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOA—alcohol dependence	7.73e-06	7.26e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—EP300—alcohol dependence	7.72e-06	7.26e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALDH2—alcohol dependence	7.68e-06	7.22e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GOT1—alcohol dependence	7.31e-06	6.87e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GGT1—alcohol dependence	7.31e-06	6.87e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—EP300—alcohol dependence	7.08e-06	6.65e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EP300—alcohol dependence	7.05e-06	6.62e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EP300—alcohol dependence	6.9e-06	6.48e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—EP300—alcohol dependence	6.55e-06	6.16e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOA—alcohol dependence	6.55e-06	6.15e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT2—alcohol dependence	6.53e-06	6.14e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.35e-06	5.97e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.14e-06	5.77e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—alcohol dependence	6.13e-06	5.76e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EP300—alcohol dependence	5.66e-06	5.31e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GOT1—alcohol dependence	5.64e-06	5.3e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GGT1—alcohol dependence	5.64e-06	5.3e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—alcohol dependence	5.34e-06	5.02e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOA—alcohol dependence	5.05e-06	4.75e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—alcohol dependence	5.03e-06	4.73e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—alcohol dependence	4.26e-06	4.01e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—EP300—alcohol dependence	4.07e-06	3.82e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—EP300—alcohol dependence	3.54e-06	3.33e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—EP300—alcohol dependence	3.34e-06	3.14e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—alcohol dependence	3.29e-06	3.09e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—EP300—alcohol dependence	2.83e-06	2.66e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—EP300—alcohol dependence	2.18e-06	2.05e-05	CbGpPWpGaD
